Day one stream one

Please enable javascript to see more information on speakers

2pm	An organizational approach to safety review teams, signal tracking, risk and B-R governance Dr Craig Hartford Dr Craig Hartford (MD, PhD) has extensive experience in major pharmaceutical company Pharmacovigilance, Benefit-Risk Management, Strategic Leadership, and prior external experience as a Clinical Investigator for several major Pharmaceutical... more.. › Dr Craig Hartford, VP, Head of product Safety Surveillance and Risk Management function in Pfizer's New York HQ Worldwide Safety function, involved with safety signal management and risk management, Pfizer
2.30pm	Use of data review tools in clinical data management for safety review and support Thomas Binnen 01.99-06.02 Medical Study Coordinator at the Institute of Health Economics and Clinical Epidemiology, University of Cologne Director Prof. Dr. med. Dr. sc. Karl W. Lauterbach 07.02-03.03 Drug Safety Officer, PAION GmbH Aachen Corporate Drug... more.. › Thomas Binnen, Medical Specialist, Clinical Data and Knowledge Management, Global Clinical Data Center, Bayer Healthcare
3pm	Lifecycle signal detection and analysis Roland Chen Roland Chen, M.D. is Vice President, Medical Safety Assessment and Strategic Capabilities at Bristol-Myers Squibb. He currently leads medical safety assessment efforts for the Cardiovascular / Metabolics therapeutic areas and also oversees efforts ... more.. › Roland Chen, Vice President, Medical Safety Assessment / Strategic Capabilities, BMS